L Hist Syrup contains Levocetirizine dihydrochloride at a concentration of 2.5 mg per 5 ml, an effective second-generation antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is a selective H1 receptor antagonist that inhibits the action of histamine, a key mediator in allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria, providing symptomatic relief from sneezing, nasal congestion, rhinorrhea, itching, and hives. L Hist Syrup offers the advantage of minimal sedation and reduced anticholinergic effects compared to first-generation antihistamines, making it suitable for pediatric and adult patients requiring long-term management of allergic conditions. The syrup formulation facilitates ease of administration, particularly in children and patients with difficulty swallowing tablets. Dosage should be adjusted according to age and clinical response, with caution advised in patients with renal impairment. Common adverse effects may include headache, dry mouth, and fatigue, though these are generally mild and transient. L Hist Syrup should be used under medical supervision, with consideration of contraindications such as hypersensitivity to levocetirizine or related compounds.